Menu Back toSession-0702-Safety-Evaluation-of-New-Types-of-Antibodies
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
The 7th DIA China Annual Meeting
Session 0702 Safety Evaluation of New Types of Antibodies
- National Institutes for Food and Drug Control, China
Current Challenges and Opportunities in Preclinical Safety Assessment of Multi-specific Biologics
- Senior Scientist/Oncology Therapeutic Area Leader
- Genentech, a Member of Roche Group, China
- Director of General Toxicology, NCSED
- CFDA, China
Preclinical Development for Monoclonal Antibody (mAb) Current Practice and Future Direction
- Executive Director & Site Lead
- Covance, China